One page, thousands of outlets. See who else covered it.
Technology behind blockbuster Covid-19 jabs is now yielding promising results in oncology treatment
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
In the second part of this three-part series, PREMIUM TIMES found that while governments approved budgets for HIV programmes, critical funds often failed to reach the health system.
A personalised vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing…
Moderna and US partner Merck are presenting study data for a new cancer vaccine - and not only fueling investors' imaginations. With mRNA, tumors could be prevented with a vaccination.
Phillip Island's tourist-attraction penguins face a disease threat after the virus was detected in a dead colony member.
Phillip Island's tourist-attraction penguins face a disease threat after the virus was detected in a dead colony member.
